In contrast, the 3.2-mg group showed marginally significant improvements compared to placebo on the HQ-CT, the PWS Anxiousness and Distress Behaviors Questionnaire, and the Clinical Global Impression of Change.
2
—
—
The sentences
The Hyperphagia Questionnaire for Clinical Trials (HQ-CT) and the Children's Yale-Brown Obsessive-Compulsive Scale showed numerical improvements in the 9.6-mg group, but these did not reach statistical significance.